Powder: -20°C for 3 years | In solvent: -80°C for 1 year
CDK9-IN-1 is a novel, selective CDK9 inhibitor for the treatment of HIV infection (IC50: 39 nM for CDK9/CycT1).
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
2 mg | 5 days | $ 46.00 | |
5 mg | 5 days | $ 97.00 |
Description | CDK9-IN-1 is a novel, selective CDK9 inhibitor for the treatment of HIV infection (IC50: 39 nM for CDK9/CycT1). |
Targets&IC50 | CDK9-CyclinT1:39 nM |
Molecular Weight | 499.54 |
Formula | C26H21N5O4S |
CAS No. | 1415559-43-1 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 25 mg/mL (50.05 mM), sonification is recommended.
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
CDK9-IN-1 1415559-43-1 Cell Cycle/Checkpoint CDK CDK-9-IN-1 CDK9IN1 CDK9 IN 1 inhibitor inhibit